Myriad Genetics | MYGN - Actif À Court Terme





Actif À Court Terme Changement Date
Agilent USD 4.76B 148M 2026-03
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Danaher USD 13.38B 554M 2026-06
Illumina USD 2.83B 96M 2026-06
J&J USD 59.77B 601M 2026-06
Mettler Toledo International USD 1.35B 15.48M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
OraSure Technologies USD 222.94M 17.84M 2026-06
Pacific Biosciences Of California USD 338.64M 30.88M 2026-06
Quest Diagnostics USD 2.84B 278M 2026-06
Quidel USD 1.38B 400K 2026-06
Repligen USD 1.2B 39.19M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Standard Biotools USD 521.45M 67.19M 2026-03
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Veracyte USD 574.78M 52.6M 2026-06
Waters USD 3.9B 186M 2026-06